Randomised, Double-blind, Placebo-controlled, Phase IIa Dose Finding Study of Single Dose GHB11L1 in Healthy Adults.
Phase of Trial: Phase II
Latest Information Update: 24 Apr 2014
At a glance
- Drugs Influenza virus delta-NS1 vaccine (Primary)
- Indications Influenza A virus H1N1 subtype; Influenza A virus H5N1 subtype; Influenza virus infections
- Focus Adverse reactions; Pharmacodynamics
- Sponsors AVIR Green Hills Biotechnology
- 04 Jan 2011 Actual initiation date changed from 13 Jan 2010 to Dec 2009 as reported by ClinicalTrials.gov.
- 04 Jan 2011 Actual end date (May 2010) added as reported by ClinicalTrials.gov.
- 04 Jan 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.